According to a recent LinkedIn post from Vektor Medical Inc, CEO Rob Krummen recently participated in Solas Day, an event organized by investor Solas BioVentures in Omaha. The post indicates that Krummen presented the company, engaged with other founders, and acknowledged the role of Solas as a key supporting partner.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests ongoing investor engagement and visibility within the healthcare innovation ecosystem, particularly among medtech-focused backers. For investors, this type of exposure can be relevant to future fundraising prospects, strategic partnerships, and validation of Vektor Medical’s vMap technology within the electrophysiology lab and broader healthcare-innovation community.